Anesiva (Nasdaq: ANSV) is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel pharmaceutical products for pain management.

Read more




Important Zingo Recall Information.

Read more

Visit www.Zingo.com

12/19/08

Anesiva Announces Changes to Its Board of Directors and Receives Notification From Nasdaq

12/16/08

Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery

11/10/08

Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring